Back to User profile » Dr Ruben Mesa
Papers published by Dr Ruben Mesa:
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
Singer JW, Al-Fayoumi S, Ma H, Komrokji RS, Mesa R, Verstovsek S
Journal of Experimental Pharmacology 2016, 8:11-19
Published Date: 16 August 2016
Profile of pomalidomide and its potential in the treatment of myelofibrosis
Gowin KL, Mesa RA
Therapeutics and Clinical Risk Management 2015, 11:549-556
Published Date: 2 April 2015
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes
Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA
OncoTargets and Therapy 2014, 7:13-21
Published Date: 17 December 2013
Ruxolitinib as an emerging treatment in myelofibrosis
Emanuel RM, Geyer HL, Mesa RA
Blood and Lymphatic Cancer: Targets and Therapy 2013, 3:11-18
Published Date: 9 March 2013
Recent developments in myelofibrosis
Tibes R, Bogenberger JM, Mesa RA
Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:125-136
Published Date: 2 July 2012